LPA and early-onset autosomal dominant Alzheimer disease: The autotaxin–LPA pathway modulates cortical glutamatergic hyperexcitability and its disruption has been associated with neuropsychiatric diseases such as altered analgesia, schizophrenia, Alzheimer disease and multiple sclerosis [61].